MGMT and glioma: In gliomas, LINE-1 methylation, a global DNA methylation marker, is proportional to MGMT promoter methylation and higher LINE-1 methylation is a favorable prognostic factor in primary GBMs, even compared to MGMT promoter methylation [26].